Biofourmis
Announced 26 Apr 2022$300.0M · Series D · Hospitals and Health Care · United States
Biofourmis brings the right care to every person, no matter where they are.
“Biofourmis is a healthcare technology company that develops clinically validated software-based therapeutics and connected care solutions for payers, biopharmaceutical companies, clinicians, and health systems. The company was founded in 2015 and is headquartered in Boston, Massachusetts.”
4 more sources tracked. Read the full press release and reporter coverage.
Sign up to read →Investors: EDBI, General Atlantic (lead), CVS Health, Openspace Ventures, existing investors.